X0206 3 2013-08-21 0 0001311596 Regado Biosciences Inc RGDO 0001579787 RMI Investments S.a.r.l. 17, RUE DES JARDINIERS LUXEMBOURG N4 L-1835 LUXEMBOURG 0 0 1 0 0001579466 RusnanoMedInvest LLC 1-ST BRESTSKAYA STR., 29/22 MOSCOW 1Z 125047 RUSSIAN FEDERATION 0 0 1 0 Series E Preferred Stock 2012-12-18 Common Stock, par value $0.001 per share 941241 D Series E Preferred Stock 2013-04-26 Common Stock, par value $0.001 per share 428747 D The shares of Series E Preferred Stock have no expiration date and shall automatically convert upon the consummation of the Issuer's initial public offering at a conversion ratio of 1 share of Series E Preferred Stock to 0.05988024 shares of common stock, for no additional consideration. The reportable securities are directly held by the Reporting Person. The Reporting Person is a wholly-owned subsidiary of RusnanoMedInvest LLC ("RMI LLC"). RMI LLC has voting and dispositive power over the shares held by the Reporting Person. RMI Investments S.a.r.l. By: /s/ Vladimir Gurdus, Director of D-Pharma LLC, the management company of RusnanoMedInvest LLC, the sole shareholder of RMI Investments S.a.r.l. 2013-08-21 RusnanoMedInvest LLC By: /s/ Vladimir Gurdus, Director of D-Pharma LLC, the management company of RusnanoMedInvest LLC 2013-08-21